Cytovance Biologics and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus Infections

NEXT STORY
The European hand sanitizer market was valued at US$ 641.7 million in 2018 and is expected to reach US$ 9,413.5 million by 2027
PREV STORY
SCENESSE® to be Prescribed in China
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 Clinical Programs

author_avatar
NASDAQ Market News

Apellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2

CRESTWOOD, Ky. and CAMBRIDGE, Ma., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. ...

author_avatar
NASDAQ Market News

NVAX DEADLINE: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Novavax, Inc. of Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm

author_avatar
NASDAQ Market News